Elevated Serum Macrophage Migration Inhibitory Factor (MIF) Concentrations in Chronic Kidney Disease (CKD) Are Associated with Markers of Oxidative Stress and Endothelial Activation

被引:46
|
作者
Bruchfeld, Annette [1 ]
Carrero, Juan J. [2 ]
Qureshi, Abdul R. [2 ]
Lindholm, Bengt [2 ]
Barany, Peter
Heimburger, Olof
Hu, Maowen [3 ]
Lin, Xinchun [3 ]
Stenvinkel, Peter
Miller, Edmund J. [3 ,4 ]
机构
[1] Karolinska Univ Hosp Huddinge, Div Renal Med, Dept Clin Sci Intervent & Technol, Karolinska Inst,CLINTEC, S-14186 Huddinge, Sweden
[2] Karolinska Inst, CLINTEC, Baxter Novum, Stockholm, Sweden
[3] Feinstein Inst Med Res, Manhasset, NY USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
基金
英国医学研究理事会;
关键词
HUMAN ATHEROSCLEROTIC PLAQUES; CHRONIC-RENAL-FAILURE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; TNF-ALPHA; INTERLEUKIN-6; MALNUTRITION; INFLAMMATION; EXPRESSION; MORTALITY;
D O I
10.2119/molmed.2008.00109
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chronic kidney disease (CKD) carries an increased risk of cardiovascular disease (CVD). Macrophage migration inhibiting factor (MIF) is a proinflammatory cytokine implicated in the pathogenesis of sepsis, autoimmune disease, atherogenesis, and plaque instability, and is a known cardiac depressant. This post-hoc, cross-sectional study examined whether MIF serum concentrations are elevated in CKD patients. Our study included CKD 3-5 patients with moderate to severe renal dysfunction (n = 257) (mean age SD; 55 +/- 12 years) and 53 controls (60 +/- 12 years). Serum MIF concentrations, measured by enzyme-linked immunosorbent assay (ELISA), were studied in relation to glomerular filtration rate (GFR), presence of CVD, outcome and inflammatory and oxidative stress markers. MIF was significantly elevated in CKD patients compared with controls (CKD: median 676 (range 118-8275 pg/mL) controls: 433 (142-4707) pg/mL: P = 0.008). MIF was also associated with 8-hydroxy-2-deoxyguanosine (8-OH-dG) levels (rho = 0.26: P = 0.001), a marker of oxidative stress, and ICAM-1 levels (rho = 0.14, P = 0.02), a marker of endothelial activation. However, the elevated MIF concentrations were neither correlated with glomerular filtration rate (GFR) nor inflammatory markers such as CRP. IL-6, and TNF. When combining MIF and IL-6 as a marker of inflammation, a significant increase in risk for CVD was found, but when analyzing all-cause mortality, this did not differ significantly with regard to mortality from inflamed patients with low MIF levels. The data suggest that increased serum MIF levels found in CKD is not caused primarily by poor renal function, but is associated with markers of oxidative stress and endothelial activation and may play a role in vascular disease associated with CKD. (C) 2009 The Feinstein Institute for Medical Research, www.feinsteininstitute.org Online address: http://www.molmed.org doi: 10.2119/molmed.2008.00109
引用
收藏
页码:70 / 75
页数:6
相关论文
共 50 条
  • [1] Elevated Serum Macrophage Migration Inhibitory Factor (MIF) Concentrations in Chronic Kidney Disease (CKD) Are Associated with Markers of Oxidative Stress and Endothelial Activation
    Annette Bruchfeld
    Juan J. Carrero
    Abdul R. Qureshi
    Bengt Lindholm
    Peter Barany
    Olof Heimburger
    Maowen Hu
    Xinchun Lin
    Peter Stenvinkel
    Edmund J. Miller
    Molecular Medicine, 2009, 15 : 70 - 75
  • [2] Elevated serum levels of macrophage migration inhibitory factor(MIF) in patients with Behcet's disease
    Kim, S
    Kim, S
    Kim, H
    Park, M
    Yoon, C
    Kim, W
    Lee, S
    Park, S
    Cho, C
    Kim, H
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 321 - 322
  • [3] Concentrations of macrophage migration inhibitory factor (MIF) in serum of patients with mental disorder
    Schott, Klaus
    Stransky, Elke
    Bernhagen, Juergen
    Richartz, Elke
    Batra, Anil
    Laske, Christoph
    Koehler, Niklas
    Bartels, Mathias
    Buchkremer, Gerhard
    NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH, 2006, 13 (03) : 145 - 146
  • [4] Elevated serum levels of macrophage migration inhibitory factor (MIF) in patients with Behcet's disease.
    Kim, SD
    Kim, SH
    Kim, HR
    Park, MK
    Yoon, CH
    Kim, WU
    Lee, SH
    Kang, I
    Cho, CS
    Kim, HY
    Park, SH
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S232 - S232
  • [5] Macrophage migration inhibitory factor (MIF) serum levels are elevated in patients with severe sepsis
    Lehmann, LE
    Schroeder, S
    Hoeft, A
    Stüber, F
    CRITICAL CARE MEDICINE, 1999, 27 (01) : A86 - A86
  • [6] Elevated levels of serum macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis
    Matsunawa, Mizuho
    Kanemitsu, Hirohito
    Wakabayashi, Kuninobu
    Odai, Tsuyoshi
    Isozaki, Takeo
    Yajima, Nobuyuki
    Miwa, Yusuke
    Kasama, Tsuyoshi
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S851 - S851
  • [7] Elevated Serum Levels of Macrophage Migration Inhibitory Factor Are Associated with Progressive Chronic Cardiomyopathy in Patients with Chagas Disease
    Cutrullis, Romina A.
    Petray, Patricia B.
    Schapachnik, Edgardo
    Sanchez, Ruben
    Postan, Miriam
    Gonzalez, Mariela N.
    Martin, Valentina
    Corral, Ricardo S.
    PLOS ONE, 2013, 8 (02):
  • [8] High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis
    Shimizu, T
    Nishihira, J
    Mizue, Y
    Nakamura, H
    Abe, R
    Watanabe, H
    Ohkawara, A
    Shimizu, H
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 116 (06) : 989 - 990
  • [9] Macrophage migration inhibitory factor (MIF) as a novel secreted oxidative stress-induced factor in cardiomyocytes
    Fukuzawa, J
    Nishihira, J
    Haneda, T
    Osaki, J
    Saito, T
    Nomura, T
    Takahashi, F
    Hirayama, T
    Hasebe, N
    Kikuchi, K
    CIRCULATION, 2001, 104 (17) : 220 - 220
  • [10] Expressions of macrophage migration inhibitory factor in patients with chronic kidney disease
    Liu, Y.
    Zhang, X.
    Liu, G.
    Huang, J.
    Pan, Y.
    Hu, Z.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2016, 19 (06) : 778 - 783